Related by context. All words. (Click for frequent words.) 86 sodium Injection 86 Genasense ® oblimersen 74 DNA RNA Medicines 73 anticancer compound 71 Panzem R 69 PROVENGE sipuleucel T 68 PI3K/Akt pathway inhibitor 67 Genasense oblimersen sodium Injection 67 PHX# 67 Locteron ® 67 candidate deforolimus 67 PrevOnco ™ 67 IRX 2 67 SinuNase TM 67 PDX pralatrexate 67 Androxal TM 67 efaproxiral 67 acyclovir Lauriad R 67 Anturol TM 67 trastuzumab DM1 T DM1 67 oral prodrug 66 lucinactant 66 Cleviprex TM clevidipine 66 targeted radiotherapeutic 66 Curaxin CBLC# 66 apricitabine ATC 66 lomitapide 66 2 methoxyestradiol 66 GLP1 INT TM 66 liposomal formulation 66 ATPace TM 66 acetonide FA 66 IL# PE#QQR 66 Panzem R NCD 66 candidate brentuximab vedotin 66 HDL Mimetic Peptide 66 LibiGel ® 66 dextofisopam 66 NeuroSTAT ® 66 Urocortin 2 66 Celacade TM technology 65 Neo Kidney Augment 65 compound INCB# 65 catheter occlusion 65 MAGE A3 ASCI 65 BrachySil TM 65 Ophena TM 65 RIGScan CR 65 SinuNase ™ 65 ApoB SNALP 65 BiovaxID TM 65 CDK cyclin dependent 65 TBC# 65 personalized cellular immunotherapy 65 candidate Zenvia 65 Anturol ® 65 polysaccharide polymer 65 candidate XP# 65 candidate Gencaro TM 65 Phase #b/#a clinical 65 molecular imaging radiopharmaceutical 65 Proellex TM 65 omecamtiv mecarbil formerly 65 investigational pharmacologically unique 65 EVIZON TM squalamine lactate 65 SPRYCEL ® 65 delivers fluocinolone acetonide FA 65 reslizumab 65 forodesine 65 compound CIP FENOFIBRATE 65 pseudobulbar affect PBA 65 generation purine nucleoside 65 please visit www.advaxis.com 64 P#X# antagonist 64 Phase III ADT 64 CINQUIL 64 paclitaxel Taxol ® 64 refractory chronic lymphocytic 64 FOLOTYN ® 64 OvaRex ® MAb 64 Azedra TM 64 YONDELIS 64 memantine HCl 64 interferon gamma 1b 64 candidate EFAPROXYN TM 64 ALN PCS 64 diagnostic radiopharmaceutical 64 Pyridorin 64 alvespimycin 64 ONCONASE R 64 liprotamase 64 Survivin antagonist 64 5 HT3 antagonist 64 oral ridaforolimus 64 candidate Liposomal Grb 64 ongoing Phase 1b 64 QNEXA ® 64 EOquin TM 64 torezolid phosphate 64 IMiDs ® 64 bucindolol hydrochloride 64 non porcine pancreatic 64 Xcytrin R 64 Phase IIb clinical trials 64 PLK1 SNALP 64 candidate epratuzumab 64 FACTIVE R gemifloxacin 64 GAMMAGARD 64 candidate TNFerade biologic 64 Romiplostim 64 hyaluronidase enzyme 64 investigational immunotherapy 64 ThermoDox ® clinical 64 ZOLINZA 64 metaglidasen 64 ISTODAX 64 phase III isavuconazole 64 refractory gout 64 CRMD# 64 virus HCV protease inhibitor 63 LymphoStat B belimumab 63 colesevelam HCl 63 arsenic trioxide injection 63 Liprotamase 63 MEK inhibitor 63 SUCCEED trial 63 hoFH 63 Zemiva TM 63 intranasal formulation 63 oncolytic virus therapies 63 HDL Selective Delipidation 63 octreotide acetate 63 IMiDs R 63 mertansine 63 CTAP# Capsules 63 Crofelemer budesonide foam 63 monoclonal antibody conjugated 63 Azedra 63 PEG SN# 63 MEK inhibitor RDEA# 63 PROVENGE ® 63 histamine dihydrochloride 63 ELACYT 63 drug ISA# 63 sulodexide 63 telomerase therapeutic 63 QNEXA 63 CEQ# 63 eniluracil 63 mitogen activated ERK kinase 63 mesylate tablets 63 Protexia ® 63 oral picoplatin 63 ATL# [001] 63 Hedgehog Pathway Inhibitor 63 sorafenib tablets 63 oral rivaroxaban 63 elotuzumab 63 Archexin 63 alvimopan 63 Quinamed 63 candidate Puricase 63 novel antifolate currently 63 novel VDA molecule 63 PNP inhibitor 63 Pivotal Phase III 63 oxymorphone ER 63 HGS ETR1 mapatumumab 63 XL# XL# XL# XL# 63 Exherin TM 63 mGluR5 negative 63 AAG geldanamycin analog 63 Zenvia Phase III 63 Glufosfamide 63 ALN VSP Phase 63 PRNewswire FirstCall Genta Incorporated 63 ICA # 63 tolevamer 63 small molecule Hedgehog 63 evaluating satraplatin 63 Ketotransdel ® 63 ThermoDox R 63 PANVAC VF 63 herpetic keratitis 63 TLK# 63 Marqibo TM 63 PROPEL trial 63 vosaroxin 63 methylnaltrexone bromide 63 PrevOnco 63 HGS ETR2 63 MGCD# [001] 63 vapreotide acetate 63 lintuzumab SGN 62 IgG1 monoclonal antibody 62 Sulonex TM 62 kidney urologic 62 oxybutynin ATD TM 62 XL# anticancer compounds 62 Phenoptin 62 inhibitor PPI 62 systemic anaplastic large 62 Dyloject TM 62 topically applied SEPA 62 Vascugel 62 Cloretazine 62 ALN HPN 62 Soliris TM eculizumab 62 CK # novel 62 INCB# [001] 62 Perforomist ™ Inhalation Solution 62 Tezampanel 62 Elagolix 62 ALV# 62 R sorafenib tablets 62 pan histone deacetylase 62 cancer neuroendocrine tumor 62 IMiDs ® compound 62 Darinaparsin 62 orBec R oral beclomethasone 62 Vidaza ® 62 Silodosin 62 subsidiaries visit http:/www.apricusbio.com 62 REG1 Anticoagulation System 62 CD# CEA 62 investigational antiplatelet agent 62 MEK Inhibitor 62 hormone LHRH antagonist 62 lenalidomide Revlimid R 62 PEGylated interferon 62 Chemophase 62 Dacogen injection 62 evaluating tivozanib 62 Cand5 62 granted Ortec 62 AMPAKINE CX# 62 Empatic ™ 62 ancrod 62 GVAX R 62 recurrent metastatic ovarian cancer 62 HuMax EGFr 62 evaluating bafetinib 62 alkylating agent 62 Phase 1a clinical 62 R#/MEM # 62 Calcium Acetate 62 PEGPH# 62 Zenvia ™ 62 thorough QT 62 LEP ETU 62 Randomized Double blind 62 PDE4 inhibitor 62 product Fentanyl TAIFUN 62 orally administered inhibitor 62 Cloretazine R VNP#M 62 Varespladib 62 OMS#HP 62 Tarceva TM 62 Prodarsan R 62 Cloretazine ® 62 CoFactor 62 rALLy trial 62 Aganocide 62 Staccato loxapine 62 Nabi HB Intravenous 62 Dapagliflozin 62 Personalized Immunotherapy 62 Abiraterone acetate 62 Ostabolin C TM 62 CYT# potent vascular disrupting 62 therapy Tovaxin 62 Hematide ™ 62 Bezielle 62 lexidronam injection 62 successfully commercialize Iluvien 62 Stedivaze 62 Onrigin 62 telomerase inhibitor drug 62 candidate CRLX# 62 ADVANCE PD 62 teduglutide 62 EFAPROXYN 62 nasal calcitonin product 61 PREOS R 61 Kamada AAT 61 non nucleoside inhibitor 61 faropenem medoxomil 61 Solazed TM 61 midstage clinical 61 CB2 selective receptor agonist 61 incyclinide 61 tiapamil 61 system REG1 consists 61 OAB overactive bladder 61 ongoing Phase IIIb 61 individualized cellular immunotherapy 61 sNDA submission 61 Anturol 61 drug GAP #B# 61 Emezine 61 balsalazide tablet 61 Fibrillex TM 61 intravenous acetaminophen 61 selective androgen receptor modulator 61 ruxolitinib 61 Zorbtive TM 61 TRO# 61 tramiprosate Alzhemed TM 61 #ME# 61 IMPACT DCM 61 nalbuphine ER 61 Vidaza azacitidine 61 orBec ® oral beclomethasone 61 Q#IR 61 GVAX ® 61 CINOD 61 Completes Patient Enrollment 61 docetaxel Taxotere R 61 Premarket Approval PMA 61 Oral NKTR 61 sapacitabine CYC# 61 Alzhemed TM 61 sulfonylurea glimepiride 61 treat opioid induced 61 TOCOSOL Camptothecin 61 Testosterone MDTS ® 61 PEGylated anti 61 NDA Submission 61 MGd 61 BEMA Granisetron 61 TELINTRA R 61 BRIM2 61 Vidaza R 61 gefitinib Iressa 61 TPI ASM8 61 cromolyn sodium 61 modified glutathione analog 61 Cetrorelix 61 Telik logo TELINTRA 61 Neo Urinary Conduit 61 histone deacetylase inhibitor 61 KNS # 61 BXT # 61 proprietary transdermal patch 61 including eniluracil ADH 61 HCV protease inhibitor 61 ospemifene 61 RANK Ligand inhibitor 61 Alocrest 61 lesinurad 61 Bayer HealthCare Onyx Pharmaceuticals 61 CORT # 61 Amplimexon 61 orBec 61 Besivance 61 targets Galectin receptors 61 highly selective inhibitor 61 Aeolus Pharmaceuticals Announces 61 Pyridorin TM 61 Foradil Aerolizer 61 SILENOR TM 61 CIP TRAMADOL ER 61 Genz # 61 Phase Ib study 61 Nexavar sorafenib tablets 61 Annamycin 61 immunosuppressive compound 61 Onalta 61 severe hypercholesterolemia 61 Phase III Pivotal 61 Aganocide R 61 BioMarck 61 Empatic TM 61 opioid induced bowel dysfunction 61 thalidomide Thalomid 61 APEX PD 61 sodium thiosulfate STS 61 candidate MyVax 61 SPL# Gel vaginal microbicide 61 JZP 61 Initiate Clinical Trial 61 dose escalation clinical 61 EXPAREL ™ 61 PRTX 61 Initiates Enrollment 61 Friedreich Ataxia FRDA 61 vidofludimus 61 Allovectin 7 61 USL# 61 oxypurinol 61 urocortin 2 61 PRT# 61 Diamyd R 61 CIP Fenofibrate 61 HEPLISAV ™ 61 lorcaserin Phase 61 ISIS # 61 Ketotransdel 61 Restanza TM 61 IAP inhibitor 61 Neuradiab 61 LEVADEX TM 61 granisetron formulated 61 vernakalant hydrochloride 61 R vancomycin hydrochloride 61 Hematide TM 61 Actimmune ® 61 custirsen 61 overactive bladder VANTAS R 61 Squalamine 61 compound PMX # 61 xanthine oxidase inhibitor 61 AeroLEF TM 61 Orathecin 61 multicenter Phase III 61 investigational monoclonal antibody 61 IMA# 61 Myocet 61 MelaFind R 60 evaluating picoplatin 60 Onrigin TM 60 Xanafide 60 hyperphenylalaninemia HPA due 60 REGN# 60 topical non steroidal 60 MKC# 60 PRECISE trial 60 candidate NGX 60 isatoribine 60 Zerenex 60 LymphoStat B TM 60 include PLX IBD 60 metformin HCl 60 Triapine R 60 trial evaluating PRX# 60 oral gallium 60 phase IIb clinical 60 HepeX B TM 60 investigational hepatitis B 60 Qutenza TM 60 HIV maturation inhibition 60 neratinib 60 regenerative therapies E1 INT 60 PSMA ADC 60 demonstrated antitumor activity 60 Proxinium TM 60 acadesine 60 allosteric modulator 60 metastatic castration resistant 60 TNFerade TM 60 COLAZAL R 60 octreotide implant 60 GALNS 60 recombinant PSMA vaccine 60 BCR ABL inhibitor 60 Muraglitazar 60 combines bupropion 60 Phase IIa trials 60 bevirimat Study 60 phase IIb III 60 CAPHOSOL R 60 Phase 1b clinical trials 60 HQK 60 Chrysalin 60 Phase 2a clinical 60 SUTENT ® 60 Phase 2a clinical trials 60 Aurexis 60 hypoxia selective 60 intravesical infusion therapy 60 BENICAR HCT 60 mGluR5 NAM 60 dasatinib Sprycel ® 60 UVIDEM 60 Prostate AdenoCarcinoma Treatment 60 anti CD3 antibody 60 Eniluracil 60 Bazedoxifene 60 pulmonology portfolio 60 mesylate tablets approved 60 maximally tolerated dose 60 SomatoKine 60 QLT# 60 AZILECT R 60 Inhalation Aerosol 60 Aflibercept 60 developing Zerenex ferric 60 histone deacetylase HDAC inhibitor 60 HoFH 60 rNAPc2 60 dextromethorphan quinidine 60 Cannabinor 60 ALN TTR 60 Phase Ib II 60 Mg Usa 60 Epanova 60 EmbraceAC 60 oral nucleoside analogue 60 Tectin TM 60 VitiGam 60 Bendamustine 60 Amrubicin 60 immune modulatory 60 Spiegelmer ® 60 R sipuleucel T 60 Tyrima 60 OvaRex R 60 Naproxcinod 60 Entereg R 60 TNF Tumor Necrosis Factor 60 ALTROPANE R 60 treat chronic sinusitis 60 Traficet EN 60 Trofex 60 pan HDAC inhibitor 60 MAA submission 60 FOLFOX6 chemotherapy regimen 60 Sapacitabine 60 candidates bavituximab 60 DAVANAT R 60 Generx TM 60 Diamyd ® 60 novel histone deacetylase 60 induced macular edema 60 AKT inhibitor 60 GATTEX ® 60 QUADRAMET R 60 phase IIb trial 60 mTOR mammalian target 60 Aerosurf 60 LibiGel testosterone gel 60 CINTREDEKIN BESUDOTOX 60 Androxal ® 60 seliciclib CYC# 60 Perflubutane Polymer Microspheres 60 drug pipeline TAFA# 60 MKC# MT 60 worsening thrombocytopenia 60 oral deforolimus 60 sulfonylhydrazine class 60 RGB # 60 systemically administered 60 Oracea TM 60 MYDICAR ® 60 Asentar 60 prGCD 60 targeting Inflammatory Bowel 60 ELADUR 60 cediranib 60 candidates Azedra TM 60 docetaxel Taxotere ® 60 Vion Pharmaceuticals 60 brivaracetam 60 GED aPC 60 cetrorelix pamoate 60 TRIOLEX HE# APOPTONE HE# 60 RhuDex ® 60 Tengion Neo Urinary Conduit 60 vinorelbine tartrate 60 Combination REOLYSIN R 60 Altera Nebulizer System 60 dimebon latrepirdine 60 Talabostat 60 R memantine HCl 60 pioglitazone HCl 60 orally inhaled migraine 60 evaluating Actimmune 60 EcoNail 60 integrin inhibitor 60 targeted antifolate 60 MAb therapy 60 selective modulator 60 Azedra ™ 60 BLA filing 60 MEND CABG 60 tezampanel 60 Intravenous CP 60 Diabetic Macular Edema 60 ® pioglitazone HCl 60 motexafin gadolinium Injection 60 Bicifadine 60 Onalta ™ 60 Hsp# Inhibitor 60 Pirfenidone 60 DUROS 60 Initiates Phase III 59 XP# XP# 59 Veronate 59 VEGFR2 inhibitor 59 Aganocide ® 59 GTC recombinant human 59 sapropterin dihydrochloride 59 RAPTIVA 59 Hedgehog antagonist 59 Xcellerated T Cells 59 HGS ETR1 59 FavId 59 Lixivaptan 59 Icatibant 59 E1 INT TM 59 EMPOWER ™ 59 ENRICH trial 59 include LibiGel ® 59 erlotinib Tarceva ® 59 gallium containing 59 CCX# 59 MERLIN TIMI 59 oritavancin semi 59 Rhucin ® 59 budesonide MMX Phase III 59 UPLYSO 59 non nucleoside HCV 59 vitamin B# folic acid 59 RLY# 59 MTP inhibitor 59 ALN TTR# 59 delta opioid receptor 59 initiate multicenter 59 Evoltra ® 59 Phase 2a trial 59 glucokinase activator 59 TRX1 59 CIMZIA ™ 59 ponatinib 59 novel orally inhaled 59 Sprycel dasatinib 59 vinca alkaloid 59 TOCOSOL Paclitaxel 59 next generation URAT1 59 synthetic retinoid 59 Dasatinib 59 brand ciclesonide HFA 59 TELINTRA 59 Kahalalide F 59 Luveris R Ovidrel R 59 Neo Kidney Augment ™ 59 oral methylnaltrexone 59 Regeneron Pharma 59 TYZEKA 59 IV Busulfex 59 PEG irinotecan 59 gemcitabine Gemzar ® 59 REG1 59 Initiates Phase II 59 trastuzumab emtansine T DM1 59 R roscovitine 59 TRISENOX ® 59 Corlux 59 LEVADEX ™ 59 candidate ATHX 59 novel DACH platinum 59 SUPPRELIN R LA 59 compound ISA# 59 adjuvant GIST 59 severe gastroparesis 59 TRANSDUR ® 59 Plicera 59 AEGR 59 Zemiva ™ 59 TKM ApoB 59 granulated mesalamine 59 Amigal TM 59 talactoferrin 59 BEMA TM Fentanyl 59 Lenocta 59 doxercalciferol 59 paclitaxel poliglumex 59 Phase #b/#a 59 investigational humanized monoclonal antibody 59 beta 1a 59 IMPDH inhibitor 59 Begins Dosing 59 CR# vcMMAE 59 JAK1 59 Solazed 59 lead molecular radiotherapeutic 59 AZILECT ® 59 preclinical pharmacokinetic 59 RiVax 59 Surfaxin LS 59 MOZOBIL 59 Perforomist TM formoterol fumarate 59 Oral Calcitonin 59 Budesonide foam crofelemer 59 OncoVEX GM CSF 59 primary hypercholesterolemia 59 SNT MC# 59 prokinetic agent 59 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 59 rHuPH# enzyme 59 JAK2 inhibitor 59 azficel T 59 R Saizen R 59 phase IIb study 59 BCX# 59 Exherin 59 candidate ridaforolimus 59 DPX Survivac 59 TRIOLEX ™ 59 PEGINTRON TM 59 dihydrochloride 59 Iluvien ® 59 PCK# 59 TAFA# 59 5 FU leucovorin 59 PEGylated Fab fragment 59 candidate Zemiva TM 59 6R BH4 59 huC# DM4 59 Xyfid TM 59 registrational 59 randomized Phase 2b 59 Protexia R 59 TYGACIL 59 MEND CABG II 59 Panzem ® 59 Ceflatonin ® 59 Randomized Phase 59 compound perifosine 59 ALN VSP 59 PF # [002] 59 Entereg TM 59 Tramiprosate ALZHEMED TM 59 Phase 2b Clinical Trial 59 oxybutynin ATD ™ 59 confirmatory Phase III 59 hormone agonist 59 ZEVALIN ® 59 relapsed refractory multiple myeloma 59 Nexavar sorafenib 59 Atiprimod 59 BLA submission 59 Mipomersen 59 Phase IIB 59 inhalation aerosol 59 VNP#M 59 markets COLAZAL 59 bazedoxifene conjugated estrogens 59 Serostim ® 59 adenosine injection 59 % uracil topical 59 VIVITROL ® 59 OMNARIS HFA 59 RSD# 59 Polymer Microspheres 59 inhaled liposomal ciprofloxacin 59 Cotara R 59 Junovan TM 59 Phase #b/#a trial 59 Ophena 59 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 59 novel emulsion formulation 59 pralatrexate 59 Pimavanserin 59 GAP #B# 59 phase IIa clinical 59 Phase 2b clinical trials 59 icatibant 59 MacuSight 59 Pruvel TM 59 CIMZIA TM 59 TSX ONY 59 indibulin 59 AeroLEF 59 Rhucin R 59 human C1 inhibitor 59 ARRY # 59 recombinant biopharmaceutical 59 Zybrestat 59 RELOVAIR ™ 59 Selective Electrochemical Tumor Ablation 59 Methylnaltrexone 59 ProLindac TM 59 MOVIPREP R 59 oral dual endothelin 59 samarium Sm 59 qualitative serum 59 candidate HuCNS SC 59 systemic RNAi therapeutic 59 MIVI III 59 ANCHOR trial 59 L MTP PE 59 Intermezzo ® zolpidem tartrate 59 Canvaxin 59 pharmacokinetic PK 59 pralatrexate injection folate analogue 59 ATRA IV 59 inflammatory autoimmune diseases 59 Immunotherapeutic 59 RenaZorb TM 59 Allovectin 7 ® 59 tanespimycin 59 Nasdaq DVAX 59 multicenter Phase II 59 Clonicel 59 Opterone R 59 EDEMA3 trial 59 NicVAX TM 59 Cellegesic 59 CYP#A# CYP#D# 59 small molecule thrombopoietin 59 Dabigatran etexilate 59 Sanvar R 59 Phase III Clinical Trial 59 adecatumumab MT# 59 MoxDuo IR 59 Bellicum Pharmaceuticals Inc. 59 Alexza Staccato 59 Metastatic Melanoma 59 atacicept 59 Cimzia TM 59 autologous cellular immunotherapy 59 ularitide 59 Ovitrelle R Serostim 59 candidates Azedra 59 thymalfasin 59 Xeloda ® 59 Tarmogen 59 IMiDs 59 XL# XL# 59 Phase #/#a trial 59 AzaSite Xtra 59 website www.celsion.com 59 Tanespimycin 59 Accelerated Partial Breast Irradiation 59 rxRNA 59 HCD# [002] 59 cardiac muscle contractility 59 Abstract Accepted 59 POSIDUR TM ELADUR TM 59 Hodgkin lymphoma HL 59 confirmatory clinical 59 Canvaxin TM 58 lumiliximab 58 Zarnestra 58 PEGylated irinotecan 58 ADP receptor antagonist 58 Arikace 58 Phase 2b kidney transplant 58 NEUMUNE 58 Nasdaq IDRA today 58 5 Fluorouracil 58 Inhalation Solution 58 methylnaltrexone 58 RECOTHROM R 58 Raptiva ® 58 Soliris eculizumab 58 Clolar ® 58 forodesine hydrochloride 58 HFA MDI 58 volociximab 58 perifosine KRX 58 antibody MAb 58 Proquin XR 58 Aztreonam 58 R metformin Concor 58 Pruvel 58 TACI Ig 58 dermal patch 58 refractory Hodgkin lymphoma 58 dutogliptin 58 dasatinib Sprycel 58 dihydrochloride Tablets 58 Amigal 58 Complicated Skin 58 PS# [001] 58 CORLUX CORT # 58 pain palliation 58 desvenlafaxine succinate 58 cortisol synthesis 58 pharmacokinetic PK study 58 prescribed proton pump 58 OLpur TM H2H 58 Huntexil 58 Initiated Phase 58 fosbretabulin 58 Omigard 58 sNDAs 58 Drug Eluting Stent System 58 Linjeta TM 58 Aplidin R 58 SNALP technology 58 GATTEX ™ 58 AEG# 58 phase IIIb 58 PRIMO CABG2 58 MCSP respectively 58 erlotinib Tarceva 58 MyVax R 58 peptidic compound 58 CERVARIX R 58 standard chemotherapy regimen 58 cutaneous T 58 Aplidin 58 cyclobenzaprine hydrochloride extended 58 OMP #R# 58 albiglutide 58 markets HP Acthar 58 Alfimeprase 58 sodium glucose transporter 58 transthyretin TTR 58 developing Zerenex TM 58 Civacir 58 GW# [003] 58 R bisoprolol Euthyrox 58 HuMax TAC 58 Aztreonam lysine 58 post operative ileus 58 BENLYSTA ® 58 ACTEMRA TM 58 Recombinant Human 58 dependent kinase inhibitor 58 product platforms AZX# 58 coronary stent merged 58 aurora kinase 58 NUVIGIL ® 58 cUTI 58 dalbavancin 58 eosinophilic asthma 58 Zalypsis 58 investigational oral hepatitis C 58 sapropterin dihydrochloride Tablets 58 R PEG uricase 58 AZX# 58 zolpidem tartrate sublingual tablet 58 external counterpulsation systems 58 Prodarsan ® 58 agonistic human 58 QRxPharma 58 tesetaxel 58 Panzem NCD 58 Parathyroid Hormone 58 leading oral taxane 58 TKM PLK1 58 visilizumab 58 defensin mimetic antibiotic 58 cinacalcet HCl 58 serine protease inhibitor CU# 58 BRILINTA 58 Temsirolimus 58 ELADUR ™ 58 class anticancer quinolone 58 Nasdaq PGNX today 58 GetGoal Phase III 58 APPRAISE 58 phase Ib 58 R#/MEM 58 Hsp# inhibitor 58 Inc. Nasdaq CYCC 58 OTCBB CTIX 58 CXB# 58 Fortical R 58 ORE# 58 Fx #A 58 5 fluorouracil leucovorin 58 RSR# 58 XL# XL# XL# 58 eritoran 58 IMPACT IMmunotherapy 58 Acetavance TM 58 Epratuzumab 58 Argatroban 58 dose escalation phase 58 KRN# 58 Fodosine 58 EOquin 58 Keppra ® levetiracetam 58 oral beclomethasone dipropionate 58 Sudhir Agrawal D.Phil 58 Nasdaq NYMX 58 liver resection surgeries 58 Biologic License Application BLA 58 Phase IIb Trial 58 Azacitidine 58 VISICOL R 58 Phase IIb III 58 FDA Approvable Letter 58 Cloretazine R 58 Aryplase 58 Diabetic Macular Edema DME 58 LE SN# 58 teriflunomide 58 Meets Primary Endpoint 58 Virulizin ® 58 Cetrorelix pamoate 58 OncoGel 58 SYCREST 58 Dual Opioid 58 CBLC# 58 tezampanel NGX# 58 OHR/AVR# 58 IIa trial 58 PTH analogue 58 Omacetaxine 58 ocular formulation 58 fidaxomicin Phase 3 58 NEBIDO 58 BENLYSTA TM 58 DIRECT Trial